Zhejiang Zhenyuan ademetionine succinate obtained new drug certificate
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Zhejiang Zhenyuan announced on July 23, 2014 that Zhejiang Zhenyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, had received the new drug certificate (Certificate No.: GDZZ h20140039) of ademetionine succinate approved and issued by the State Food and drug administration At the same time, Zhenyuan pharmaceutical has received the drug registration approval document of ademetionine butylsulfonate bulk drug and ademetionine butylsulfonate for injection (specification: 500mg) approved and issued by the State Food and drug administration The approval document No is gjzz h20140078 and h20143203, and the registration classification is category 3.1 and category 6 of chemical drugs The validity of the approval document No is until June 26, 2019.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
